Health bosses have pledged to bring in new treatments to try to deal with ‘poor survival rates’ from prostate cancer.
It comes as figures reveal more men diagnosed with prostate cancer in Doncaster go on to die of the illness than the national average.
Prostate Cancer UK has called for for an investigation into the ‘postcode lottery’ which means some standards of care differ depending on where in the country you live.
In Doncaster, per 100,000 population, 103.5 men are diagnosed each year. The national average is higher, at 105.8.
But in the borough, 24.1 of those 103.5 men will go on to die – a figure higher than the national average of 24.
Doncaster’s director of public health Dr Tony Baxter said: “We recognise that we do have higher mortality and poor survival rates. However we are working with colleagues throughout the NHS to test more that are at risk. We are also using new treatments.
“Prostate cancer is also a priority for the clinical commissioning group.”
Drew Lindon, head of policy and campaigns at Prostate Cancer UK, said he was worried about the national variations in mortality rates.
He added: “It is certainly worrying that there is such wide variation in mortality rates for prostate cancer across the country.
“However there are a number of factors which could contribute to these trends, such as risk factors including black ethnicity, attitudes towards health and awareness of the disease or, more worryingly, variations in the standard of treatment or uptake of a test.
“This is why we are campaigning for the removal of proposed illogical restrictions on access to breakthrough drug enzalutamide in England and Wales – restrictions not faced by those in Scotland.”
Prostate cancer occurs when normal, healthy cells begin to reproduce uncontrollably in the prostate gland.
In most cases the growth is slow, and the cancer can go undetected for many years because it causes very few symptoms.
In some cases, however, prostate cancer grows quickly and may spread to other parts of the body.